Network origin in Xiao Tian Zhu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
QILU Regor Therapeutics, Inc.
3
| Private Company | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Xiao Tian Zhu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Regor Therapeutics Group
 Regor Therapeutics Group Miscellaneous Commercial ServicesCommercial Services Regor Therapeutics Group is a biotech company founded in 2018 by a team of scientists with expertise in drug discovery and development. The company is based in Boston, MA and has subsidiaries in China. Regor Therapeutics Group utilizes its industry-leading core strength in Rcard™ to accelerate the discovery of innovative therapeutic agents. The company has completed 8 PCCs in-house, with 5 INDs filed, and has a pipeline of leading assets in metabolism, oncology, and auto-immunity. The company's two leading assets are RGT-075, an orally bioavailable small molecule GLP1R full agonist with potential for obesity and beyond, and RGT-419B, a unique CDK4+ inhibitor showing outstanding single agent responses in refractory ER+/HER2- breast cancer patients. The company was founded in 2018, and the CEO is Xiayang Qiu. | Miscellaneous Commercial Services | Chief Executive Officer Chief Operating Officer |
Statistics
International
| United States | 2 |
Sectoral
| Commercial Services | 2 |
Operational
| Founder | 3 |
| Chief Executive Officer | 2 |
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Xiayang Qiu | 2 |
| Min Zhong | 2 |
| Wen Ge Zhong | 1 |
- Stock Market
- Insiders
- Xiao Tian Zhu
- Company connections
